Literature DB >> 3318830

Demonstration of phosphatidylinositol anchors on Ly-6 molecules by specific phospholipase C digestion and gel electrophoresis in octylglucoside.

J W Hammelburger1, R G Palfree, S Sirlin, U Hämmerling.   

Abstract

Release by phosphatidylinositol-specific phospholipase C is frequently provided as evidence for membrane anchorage of a protein through phosphatidylinositol. Demonstration that the enzyme removes a lipophilic moiety from the protein is stronger evidence, and is presented here for members of the Ly-6 family of lymphocyte antigens: Ly-6A, C and E. Treatment of these molecules with the enzyme greatly increased their electrophoretic mobilities on polyacrylamide gels containing nonionic detergent. Furthermore, the mobilities of the digested, but not native Ly-6 molecules, were independent of detergent. This analytical method was applied to pure antigen, radiolabelled immunoprecipitate, or immunochemically detected Ly-6 antigens on blots.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318830     DOI: 10.1016/s0006-291x(87)80275-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Biosynthesis of a phosphatidylinositol-glycan-linked membrane protein: signals for posttranslational processing of the Ly-6E antigen.

Authors:  B Su; A L Bothwell
Journal:  Mol Cell Biol       Date:  1989-08       Impact factor: 4.272

2.  Gene for human CD59 (likely Ly-6 homologue) is located on the short arm of chromosome 11.

Authors:  U H Forsberg; V Bazil; I Stefanová; J Schröder
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

3.  Analysis of three distinct Ly6-A-related cDNA sequences isolated from rat kidney.

Authors:  S Friedman; R G Palfree; S Sirlin; U Hämmerling
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

4.  Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59.

Authors:  W D Ratnoff; J J Knez; G M Prince; H Okada; P J Lachmann; M E Medof
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

5.  Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family.

Authors:  M A Degli-Esposti; P J Smolak; H Walczak; J Waugh; C P Huang; R F DuBose; R G Goodwin; C A Smith
Journal:  J Exp Med       Date:  1997-10-06       Impact factor: 14.307

6.  Altered proliferative response by T lymphocytes of Ly-6A (Sca-1) null mice.

Authors:  W L Stanford; S Haque; R Alexander; X Liu; A M Latour; H R Snodgrass; B H Koller; P M Flood
Journal:  J Exp Med       Date:  1997-08-29       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.